Tricuspid Valve sessions from EuroPCR 2025: Abbott

Sponsored by Abbott

Tricuspid Valve session from EuroPCR 2025

Enhancing clipping solutions for durable long-term patient outcomes

Discussants: S. Baldus, V. Delgado, F. De Marco, M. Keßler, F. Maisano, V. Ninios, T. Patterson, F. Sarnago, D. Tchetche, A. Vazir, W. Wojakowski

Tricuspid Valve interview from EuroPCR 2025

Tricuspid TEER: learnings from the 2-year outcomes of TRILUMINATE Pivotal trial & bRIGHT study

Discussants: M. Adamo, R. S. von Bardeleben 

Tricuspid Valve sessions from PCR London Valves 2024

Unlocking the potential of mitral and tricuspid valves clipping

Discussants: D. Arzamendi, A. Cook, E. Heng, B. Kaufmann, C. H. Li, F. Maisano, T. Nestelberger, M. Swaans, M. Taramasso

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

Discussants: N. Ajmone Marsan, A. Asgar, S. Baldus, E. Donal, G. Filippatos, F. Kreidel, G. Leurent, P. Lurz, G. Nickenig, R. S. Von Bardeleben

Tricuspid Valve sessions from EuroPCR 2023

Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)

Discussants: F. Praz, N. Dumonteil, C. Besler, P. Lurz, P.Sorajja, N.Wunderlich, M.Wild

What does TRILUMINATE Pivotal mean for my patients?

Discussants: F. Maisano, L. Sondergaard

Clinical data

Triluminate Pivotal: randomised TRIAL for tricuspid regurgitation

Speaker: P. Sorajja

Consult presentation

Real-world outcomes for TEER 30 day results from the TriClip bRIGHT study

Speaker: P. Lurz

Consult presentation

Page published on May 2023